The post hoc analysis comparing the severity grades of chemoradiotherapy-induced oral mucositis scored between the central and local assessors in a multicenter, randomized controlled trial of rebamipide for head and neck cancer

BACKGROUND: In the treatment of head and neck cancer, severity of chemoradiotherapy-induced oral mucositis has been recognized as one of the key factors affecting the outcomes of the anticancer therapies. Therefore, the development of treatments mitigating oral mucositis would be of clinical signifi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ueno, Takao, Zenda, Sadamoto, Konishi, Tetsuhito, Yurikusa, Takashi, Shibasaki, Yoshiyuki, Nagamoto, Hisashi, Fujii, Masato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399175/
https://www.ncbi.nlm.nih.gov/pubmed/30426268
http://dx.doi.org/10.1007/s10147-018-1355-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6399175/
https://www.ncbi.nlm.nih.gov/pubmed/30426268
http://dx.doi.org/10.1007/s10147-018-1355-7

Ejemplares similares